ArticleBMC pulmonary medicine2023

A selective CB2R agonist (JWH133) protects against pulmonary fibrosis through inhibiting FAK/ERK/S100A4 signaling pathways.

Xiao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.